Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries

被引:29
作者
Meulen, Ajoke Sobanjo-ter [1 ]
Duclos, Philippe [2 ]
McIntyre, Peter [3 ]
Lewis, Kristen D. C. [1 ]
Van Damme, Pierre [4 ]
O'Brien, Katherine L. [5 ]
Klugman, Keith P. [1 ]
机构
[1] Bill & Melinda Gates Fdn, Seattle, WA USA
[2] WHO, Geneva, Switzerland
[3] Univ Sydney, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia
[4] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA
基金
比尔及梅琳达.盖茨基金会;
关键词
pertussis; infants; neonates; maternal immunization; vaccines; BORDETELLA-PERTUSSIS; HOSPITALIZED INFANTS; VACCINATION COVERAGE; TDAP IMMUNIZATION; PREGNANCY; INFECTION; EPIDEMIOLOGY; PREVALENCE; RESURGENCE; SEROPREVALENCE;
D O I
10.1093/cid/ciw530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Implementation of effective interventions has halved maternal and child mortality over the past 2 decades, but less progress has been made in reducing neonatal mortality. Almost 45% of under-5 global mortality now occurs in infants < 1 month of age, with approximately 86% of neonatal deaths occurring in low-and lower-middle-income countries (LMICs). As an estimated 23% of neonatal deaths globally are due to infectious causes, maternal immunization (MI) is one intervention that may reduce mortality in the first few months of life, when direct protection often relies on passively transmitted maternal antibodies. Despite all countries including pertussis-containing vaccines in their routine childhood immunization schedules, supported through the Expanded Programme on Immunization, pertussis continues to circulate globally. Although based on limited robust epidemiologic data, current estimates derived from modeling implicate pertussis in 1% of under-5mortality, with infants too young to be vaccinated at highest risk of death. Pertussis MI programs have proven effective in reducing infant pertussis mortality in high-income countries using tetanus-diphtheria-acellular pertussis (Tdap) vaccines in their maternal and infant programs; however, these vaccines are cost-prohibitive for routine use in LMICs. The reach of antenatal care programs to deliver maternal pertussis vaccines, particularly with respect to infants at greatest risk of pertussis, needs to be further evaluated. Recognizing that decisions on the potential impact of pertussis MI in LMICs need, as a first step, robust contemporary mortality data for early infant pertussis, a symposium of global key experts was held. The symposium reviewed current evidence and identified knowledge gaps with respect to the infant pertussis disease burden in LMICs, and discussed proposed strategies to assess the potential impact of pertussis MI.
引用
收藏
页码:S123 / S133
页数:11
相关论文
共 71 条
[11]  
Centers for Disease Control and Prevention, VACC IMM WHOOP COUGH
[12]  
Cherry J D, 1984, Curr Probl Pediatr, V14, P1
[13]   Epidemic Pertussis in 2012-The Resurgence of a Vaccine-Preventable Disease [J].
Cherry, James D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :785-787
[14]   Burden of Pertussis Is Underestimated in South Korea: a Result from an Active Sentinel Surveillance System [J].
Choe, Young June ;
Kim, Jun Woo ;
Park, Young-Joon ;
Jung, Chaewon ;
Bae, Geun-Ryang .
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2014, 67 (03) :230-232
[15]   A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013 [J].
Dabrera, Gavin ;
Amirthalingam, Gayatri ;
Andrews, Nick ;
Campbell, Helen ;
Ribeiro, Sonia ;
Kara, Edna ;
Fry, Norman K. ;
Ramsay, Mary .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (03) :333-337
[16]   The pertussis enigma: reconciling epidemiology, immunology and evolution [J].
de Celles, Matthieu Domenech ;
Magpantay, Felicia M. G. ;
King, Aaron A. ;
Rohani, Pejman .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2016, 283 (1822)
[17]   What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London [J].
Donaldson, Beverly ;
Jain, Prerna ;
Holder, Beth S. ;
Lindsay, Benjamin ;
Regan, Lesley ;
Kampmann, Beate .
VACCINE, 2015, 33 (43) :5822-5828
[18]   Safety of pertussis vaccination in pregnant women in UK: observational study [J].
Donegan, Katherine ;
King, Bridget ;
Bryan, Phil .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[19]  
ENGLUND JA, 1995, PEDIATRICS, V96, P580
[20]   Pertussis in Latin America: epidemiology and control strategies [J].
Falleiros Arlant, Luiza Helena ;
de Colsa, Agustin ;
Flores, Dario ;
Brea, Jose ;
Avila Aguero, Maria L. ;
Flavia Hozbor, Daniela .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (10) :1265-1275